Leopoldo Martín Baiza-Durán

Laboratorios Sophia (Mexico) — Mexico

Medicine · Health Sciences

12h-index362citations68works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glaucoma and retinal disorders(31), Ocular Surface and Contact Lens(20), Retinal Diseases and Treatments(14), Ocular Infections and Treatments(9), Pharmacovigilance and Adverse Drug Reactions(9)

Publications68 total

Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab
Biologicals·2023· 2 citedOpen Access
Efficacy and Safety of an Ophthalmic DMPC‐Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical Trial
Journal of Ophthalmology·2023· 5 citedOpen Access
Ocular Cyclopentolate: A Mini Review Concerning Its Benefits and Risks
Clinical ophthalmology·2022· 27 citedOpen Access
Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases
Healthcare·2022· 4 citedOpen Access
Underreporting and Triggering Factors for Two Ophthalmic Drugs’ ADR Notification; A Comparison between Spontaneous Reporting and Active Pharmacovigilance Databases
Preprints.org·2022· 1 citedOpen Access
Underreporting and Triggering Factors for Ophthalmic Drugs’ ADR Notification; a Comparison between Spontaneous Reporting and Active Pharmacovigilance Databases
Preprints.org·2022Open Access
Underreporting and Triggering Factors for Ophthalmic Drugs’ ADR Notification; a Comparison between Spontaneous Reporting and Active Pharmacovigilance Databases
Preprints.org·2022· 1 citedOpen Access
Evaluation of the Rheological Properties, Preclinical Safety, and Clinical Effectiveness of a New Dispersive Ophthalmic Viscoelastic Device for Cataract Surgery
Medical Devices Evidence and Research·2022· 2 citedOpen Access
Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate
Animal Models and Experimental Medicine·2022· 14 citedOpen Access
Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]
SHILAP Revista de lepidopterología·2022Open Access
Novel therapies for proliferative retinopathies
Therapeutic Advances in Chronic Disease·2022· 7 citedOpen Access
Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
Therapeutics and Clinical Risk Management·2021· 3 citedOpen Access
Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination’s Safety Profile in Peruvian Population
Integrated Pharmacy Research and Practice·2021· 3 citedOpen Access
Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population
Drug Healthcare and Patient Safety·2021· 4 citedOpen Access
Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab
Journal of Experimental Pharmacology·2021· 6 citedOpen Access
Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination
Clinical ophthalmology·2021· 4 citedOpen Access
A Drug Safety Surveillance Study of a Ciprofloxacin/Dexamethasone Ophthalmic Fixed Combination in Peruvian Population
Pharmacy·2021· 4 citedOpen Access
Efficacy and Safety of Sodium Hyaluronate/chondroitin Sulfate Preservative-free Ophthalmic Solution in the Treatment of Dry Eye: A Clinical Trial
Current Eye Research·2020· 30 citedOpen Access
A drug safety surveillance study of a ciprofloxacin / dexamethasone ophthalmic fixed combination in Peruvian population
Preprints.org·2020· 1 citedOpen Access
Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
2020Open Access
page 1 of 4Next →

Frequent Co-authors

Oscar Olvera‐Montaño(17), Patricia Muñoz‐Villegas(15), Juan D Quintana-Hau(12), Homero Contreras-Salinas(9), Lourdes Yolotzin Rodríguez-Herrera(9), Alejandra Sánchez‐Ríos(8), R. Tornero–Montaño(7), Jaime R González(5), Pedro Gomez‐Bastar(5), Mariana Barajas-Hernández(5), Victoria E Sánchez-Castellanos(4), Andrea Anaid Navarro-Sánchez(4), Angélica Yussett Contreras-Rubio(4), Manuel Alejandro Bautista-Castro(4), Javier Medrano-Palafox(3), Juan Carlos Ochoa-Tabares(3), Abraham Soto-Gómez(3), Rubén Suárez-Velasco(3), Vanessa Orozco-Ceja(3), Jesús Jiménez-Román(3)